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Abstract The objective of the present pilot study is to
evaluate the effectiveness of three conventional contralat-
eral routing of sound (CROS) hearing aids in adults with
unilateral inner ear deafness. The study included tertiary
referral center. Ten patients with unilateral inner ear
deafness and normal hearing in the contralateral ear were
selected to evaluate three different methods of ampliﬁca-
tion: the CROS hearing aid, the completely in the canal
hearing aid and the bone-anchored hearing aid CROS
(BAHA). Each of the three hearing aids was tried in a
random order for a period of 8 weeks. Audiometric per-
formance, including speech-in-noise, directional hearing
and subjective beneﬁt were measured after each trial per-
iod, using the APHAB, SSQ and single-sided deafness
questionnaire. Sound localization performance was essen-
tially at chance level in all four conditions. Mixed results
were seen on the other patient outcome measures that
alternated in favor of one of the three CROS devices. After
the trial, three patients chose to be ﬁtted with the BAHA
CROS and one with the conventional CROS. In conclusion,
most of the patients experienced some degree of beneﬁt
with each of the three hearing aids. Preference for one of
the three hearing aids was independent of the order in
which they were tried. It would be worthwhile to formulate
selection criteria; still, we recommend that all patients with
unilateral inner ear deafness should be offered a trial with
at least the BAHA CROS.
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Introduction
Before considering a hearing aid in patients with single-
sided deafness (SSD), it is important to investigate their
medical and social backgrounds. Harford and Dodds [1]
were among the ﬁrst who advocated contralateral routing
of sound (CROS) ampliﬁcation for such patients to elimi-
nate head shadow. These authors found that the degree of
success depended on the motivation of the patient and the
listening demands imposed by their lifestyle and working
environment. They applied what is nowadays known as the
‘‘conventional CROS’’ device. It comprises a microphone
placed near the impaired ear and an ampliﬁer (hearing aid)
near the normal ear. The signal is presented to the normal
ear via an open ear mould. Conventional CROS devices
only transmit the frequencies of above 1,000 Hz through
this open ear mould, which results in a ‘‘tinny’’ sound that
might help the patient to localize sounds. Acceptance of
this conventional CROS device by the patients was related
to the level of hearing in their best ear. When hearing was
within normal limits, the success rate was low: only one
out of 12 patients accepted the CROS device. However,
when mild high frequency hearing loss was present, the
success rate was increased to 54% [1].
Lotterman and Kasten [2] studied the effect of a con-
ventional CROS device when words were presented against
a background of cafeteria noise. They observed favorable
results when the speech was presented near the impaired
ear, but unfavorable results when the speech was presented
near the normal ear. Markides [3] reported similar results.
He also tested directional hearing, but found that none of
his patients could localize sounds.
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impaired hearing side and transmitted by a wire around
the neck, or by wireless FM transmission, to the best ear
[4, 5]. However, many patients ﬁnd it unpleasant to have
an ear mould in their best ear and a cord around their
neck. The ear mould causes at least partial occlusion of
the best ear, which is a key consideration; because the
adaptive behavior learned by individuals with unilateral
hearing loss often involves turning the best ear towards
the sound source. Nowadays, the conventional CROS is
available with wireless FM transmission; however, the
wire around the neck is still used in the test setting as this
is known to have little effect on the hearing results, but
the FM link is more accepted from an esthetic point of
view.
Another option is the use of bone conduction in the form
of a ‘‘transcranial CROS’’ device. In 1960, Fowler [6]
suggested the use of a bone conduction hearing aid (in a
spectacle frame) near the deaf ear. This would stimulate the
normal cochlea (cross stimulation) by bone conduction i.e.
through the skull. No results of this application were pre-
sented at that time. Probably, the ﬁrst, comprehensive study
on transcranial CROS via bone conduction was published
in 1991 by Welling et al. [7]. They used the implantable
audiant bone conductor and reported positive results in
some of their patients. One of the main limitations of their
device was insufﬁcient output [8].
In 2000, Vaneeclo et al. [9]. applied the more powerful
BAHA (bone-anchored hearing aid) as a transcranial
CROS device in patients with unilateral inner ear deafness.
High patient satisfaction was reported as well as
improvements in directional hearing. Later on, other stud-
ies also showed high patient satisfaction, but the
improvements in directional hearing could not be repli-
cated, which drew attention to the sound localization
problems in patients with unilateral inner ear deafness [10–
12]. Good speech-in-noise results reﬂected the beneﬁt of a
BAHA CROS in lifting the head shadow while the compact
design avoided some of the disadvantages of a conven-
tional CROS. Therefore, the BAHA CROS is becoming
more and more popular in patients with unilateral inner ear
deafness [13].
Another option for patients with unilateral inner ear
deafness was introduced in the late 1980s [14]. It com-
prised a high-power conventional air conduction hearing
aid, with a relatively long ear mould that ﬁt deeply into the
patient’s deaf ear and left the best ear unoccluded. When
the ampliﬁed signals were loud enough they caused
vibration of the bony walls of the ear canal and middle ear,
which stimulated the normal ear by means of bone con-
duction through the skull. To achieve substantial gain and
to overcome the interaural attenuation of the skull, very
tight ﬁtting is required, i.e. deep within the bony ear canal.
This application, therefore, forms an alternative transcra-
nial CROS device that is ﬁtted completely in the canal
(CIC). Valente et al. [15] reported a success rate of 50% in
their patients, which was high in comparison with their
success rate of 10% with conventional CROS application.
The improvement was ascribed to better sound quality: the
harshness or tinny sound was gone. Hayes and Chen [16]
also reported on the CIC device, but their study group only
comprised three cases. As far as we know, little attention
has been paid to this type of transcranial CROS method,
since then [14, 17].
Faced with the increasing demands of communication
skills in modern society, professionals are being urged
more and more to recognize the detrimental effects of
unilateral inner ear deafness. Currently, these patients can
choose to learn various coping strategies, or they can give
preference to receive unilateral ampliﬁcation by means of a
CROS hearing aid. Little has been published about the
conventional CROS hearing aid or the CIC device.
Although mostly poor results have been reported in the few
available studies, some patients do beneﬁt from these forms
of CROS application.
Recently, many patients with unilateral sensorineural
hearing loss become aware of the BAHA CROS option,
not least due to its high proﬁle on the internet [18].
Baguley et al. reviewed the published studies to empha-
size the need for evidence base for the application of the
BAHA CROS in these patients with SSD [18]. The
reviewed studies found evidence of improved perfor-
mance with the BAHA CROS [10, 11, 19]. However,
Baguley et al. [18] criticized these studies on methodo-
logical aspects. All the studies, however, recommended
careful selection of patients for the BAHA CROS as it was
particularly advantageous in speciﬁc listening situations,
but did not lead to objectively measurable improvements
in directional hearing. Baguley et al., therefore, advised
clinicians to proceed with caution and to await the out-
come of a larger randomized trial [18, 20]. The largest
series of patients in our clinic with unilateral sensorineural
hearing loss who have been ﬁtted with a BAHA CROS
recently reached 56 [21]. These patients were selected on
the basis of a preoperative trial with the BAHA CROS on
a headband. On an average, the majority of these 56
patients are satisﬁed [21].
On the account of the criticism from Baguley, we per-
formed a pilot study in which the three currently available
CROS devices (conventional CROS, CIC and BAHA
CROS) were assigned in random order to ten adult patients
with unilateral sensorineural hearing loss for a test period
of 8 weeks per device.
The evaluation comprised audiometric testing and
patient outcome measurements on three hearing speciﬁc
instruments to quantify subjective beneﬁt.
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Patients
At our outpatient clinic, we recruited ten adult patients with
unilateral sensorineural hearing loss. These patients had not
necessarily visited our outpatient clinic to obtain infor-
mation about hearing aids. They were invited to participate
in a prospective trial with three different methods of uni-
lateral ampliﬁcation: the conventional CROS (CROS), the
CIC and the BAHA CROS on a headband (BAHA).
Each subject’s unaided performance provided a baseline
measurement to assess the effectiveness of the CROS
devices. All the patients had normal hearing (PTA\25 dB)
in the contralateral ear with a mean PTA of 12 dBHL.
These thresholds meet the current conventional criteria for
the SSD indication. Two patients had congenital unilateral
hearing loss, the other eight patients had acquired unilateral
hearing loss due to acoustic neuroma excision (n = 1),
trauma (n = 3), meningitis (n = 2) and sudden deafness
with cause unknown (n = 2). Average duration of deafness
was 23 years (range 1–56). Table 1 presents an overview of
gender, age, etiology and duration of unilateral hearing
loss.
Methods
Patients were offered a trial period with each of the three
CROS devices for a period of 8 weeks in a random order.
This duration is based on the literature on acclimatization
by Gatehouse [22]. The conventional CROS test device
consisted of a behind the ear hearing aid with a wire around
the neck (Widex B2 with Widex CROS unit on the con-
tralateral side). The Beltone deeply ﬁtted device comprised
a P60PP CIC hearing aid, which was tested after a deeply
ﬁtted patient-speciﬁc mould had been made. Fitting
parameters of both devices were set according to the
speciﬁcations of the manufacturer. The frequency response
of the hearing aids was set to a maximally ﬂat response. The
gain of the CIC was set to the feedback limit. The effec-
tiveness of the transcranial CIC is assessed by means of
standard procedures. The BAHA CROS was worn on a steel
headband with adequate coupling force, as a good relation
(transcutaneous vs. percutaneous loss is around 10 dB) is
seen between the results with the headband and the BAHA
on an implant [23, 24]. Of course, the BAHA on a headband
is the only option to test the device on a trial basis.
Patients were encouraged to use the devices on a daily
basis. The CROS devices were ﬁtted without providing any
information about efﬁcacy or comfort. At the end of the
trial, the patients were asked whether they felt that the
CROS ampliﬁcation had been worthwhile and which of the
three CROS devices (if any) took their preference.
Evaluations were made in four different conditions:
unaided, with the conventional CROS, with the CIC
hearing aid and with the BAHA CROS on a headband.
The data obtained in the unaided condition served as a
baseline measurement to assess the effectiveness of the
hearing aids. Afterwards, the patients were ﬁtted with one
of the three devices for a trial period of 8 weeks. In all four
conditions, the audiometric evaluation consisted of sound
localization measurements with a 9-speaker array at 30,
for details see Bosman et al. [25]. From that experiment,
we deleted the response to 0 azimuth stimulation and
determined simply whether the respond was on the side of
the stimulation; this is referred to as the lateralization
score. Speech perception was measured using short,
everyday Dutch sentences [26]. Spectrally, shaped noise at
a ﬁxed level of 65 dB was presented in front of the listener
(at azimuth 0) and speech at ?90 or at -90 azimuth and
vice versa. Speech reception thresholds were measured
with the ‘‘one up-one down’’ adaptive tracking procedure
Table 1 Patient characteristics: gender, age, etiology, duration of unilateral deafness and average pure tone average (PTA) in dBHL at the
frequencies 500, 1,000 and 2,000 Hz in the normal ear
Patient Gender Age (years) Etiology Duration (years) PTA BC PTA AC
1 M 31 Congenital 31 8.3 13.3
2 M 51 Trauma 41 8.3 8.3
3 M 64 Acoustic neuroma 10 0.0 3.3
4 F 56 Congenital 56 5.0 5.0
5 M 45 Trauma 1 8.3 8.3
6 F 28 Meningitis 27 13.3 18.3
7 M 47 Trauma 3 23.3 25.0
8 F 44 Sudden deafness 1 13.3 13.3
9 F 53 Meningitis 41 13.3 13.3
10 M 43 Sudden deafness 18 8.0 8.0
AC air conduction, BC bone conduction
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surement setup as in our previous studies was chosen to
avoid methodological differences.
Patient outcome measures
The baseline (unaided) and post-intervention measure-
ments were conducted using two validated instruments in
the Dutch language: the abbreviated proﬁle of hearing aid
beneﬁt (APHAB) [27] and the speech, spatial and qualities
(SSQ) of hearing proﬁle [28]. The general SSD question-
naire was added to obtain more speciﬁc information.
Patients were asked to ﬁll out the post-intervention
instruments at the end of each trial period after 8 weeks of
experience with each device.
The abbreviated proﬁle of hearing aid beneﬁt (APHAB)
[27] consists of 24 items in the following domains: ease of
conversation (EC), listening under reverberant conditions
(RV), listening in background noise (BN) and aversiveness
to loud sounds (AV). Higher scores reﬂect more problems.
The SSQ of hearing scale [28] measures beneﬁt on the
domains spatial hearing, speech perception and quality of
sounds. As the spatial hearing domain is presumed to be of
importance to binaural hearing, we only used the 16 items
from the spatial hearing domain of the questionnaire (e.g.
locate speaker round a table, locate dog barking, judge
distance of a vehicle, etc.). High scores reﬂect good per-
formance. This instrument is thought to be sensitive to
auditory disabilities associated with SSD, especially.
The 12-item SSD questionnaire [29] was also adminis-
tered to obtain data on the use, satisfaction, estimation of
hearing aid beneﬁt in different listening situations in
comparison with the unaided situation, esthetics and han-
dling of the CROS devices. This questionnaire has been
used in previous studies on unilateral inner ear deafness
[29].
Results
General
One patient did not participate in all unaided audiometric
measurements. Two patients could not be ﬁtted with the
completely in the CIC, due to an enlarged external meatus
secondary to tumor excision. One of these two patients
dropped out, resulting in both CIC and CROS measure-
ments were lacking. Another patient tried all three hearing
aids, but was unable to complete the audiometric testing. In
addition, for this patient most of the questionnaires were
too difﬁcult to ﬁll out adequately, even with assistance. All
the patients ﬁlled out the patient outcome measures in
nearly all the conditions. When data were missing, this is
speciﬁed.
Source localization
Sound localization performance was essentially at chance
level in all four conditions. Data on lateralization (left/
right) scores are shown in Table 2.
Speech recognition
Speech reception thresholds (SRTs) in noise in all four
conditions are shown in Fig. 1. Better performance corre-
sponds with lower signal-to-noise ratios. Data were col-
lected with the noise in front, while the speech was
presented on either the profoundly deaf side (PE) or the
normal hearing side (BE). This condition was called lateral
speech. In the unaided condition (see Fig. 1), the S/N ratio
when the speech was presented on the deaf side with the
noise in front was about 0.5 dB. In the aided conditions,
these S/N ratios were better with the conventional CROS
(reduced to about -1.7 dB), slightly poorer with the
BAHA CROS (0.4 dB) and somewhat poorer with the CIC
(about 0.7 dB).
When the speech was presented on the normal side (best
ear = BE), the S/N ratio in the unaided condition was
-4.3 dB. With the conventional CROS, the CIC and the
BAHA CROS, these S/N ratios were -2.7, -4.6 and
-2.0 dB, respectively.
Outcome measures
Abbreviated proﬁle of hearing aid beneﬁt
Scores on the different domains of the APHAB are shown
in Fig. 2. The lower the score, the better is the outcome.
Table 2 Average sound lateralization scores using 500 and 3,000 Hz stimuli in four conditions: unaided, conventional CROS (CROS),
completely in the canal (CIC) and BAHA CROS (BAHA)
Chance level
(%)
Frequency
(Hz)
Unaided (%)
(n = 10)
CROS (%)
(n = 8)
CIC (%)
(n = 7)
BAHA (%)
(n = 9)
Lateralization 50 500 53.6 53.0 53.3 56.1
3,000 61.0 48.6 70.4 58.9
Chance level for lateralization (50%) is shown
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the domains EC (22), BN (61) and RV (38). All three
hearing aids showed deterioration on the domain AV. The
least deterioration was seen with the conventional CROS
(40).
The CIC showed an improved score on the domain EC
(26), but poorer scores on the other domains BN (73), RV
(53) and AV (40).
The BAHA CROS showed the largest improvement on
the domain EC (18) and less pronounced improvement on
the domain BN (54). The scores were poorer on the
domains RV (46) and AV (42). Overall, the conventional
CROS had the best scores on the APHAB domains.
Speech, spatial and qualities
The results are presented in Table 3, the higher scores, the
better is the outcome. The mean score on the spatial
domain in the unaided condition (n = 10) was 3.7 on a
scale from 0 to 10. In the aided conditions with the CROS
(n = 8), CIC (n = 8) and BAHA (n = 9) the mean scores
were better: 1.3, 0.3 and 1.1, respectively.
Speech, spatial and qualities
Most of the patients used each of the CROS devices more
than 8 h a day (CIC), or 4–8 h a day (CROS, BAHA), 6–
7 days a week. With the CIC, the best subjective scores
were found on the domains wearing comfort, easy to use,
rustle, whistle and failure. Lower scores were assigned to
the conventional CROS and the BAHA CROS. In contrast,
most of the patients (n = 6) said that the BAHA CROS
was beneﬁcial to hearing, whereas the CIC was of no
beneﬁt (n = 6) (see Fig. 3). The average score on several
quality of sound items was best with the CROS (7 on a
-5,0
-4,0
-3,0
-2,0
-1,0
0,0
1,0
Lateral speech (BE)
Unaided
CROS
CIC
BAHA
-5,0
-4,0
-3,0
-2,0
-1,0
0,0
1,0
Lateral speech (PE)
Unaided
CROS
CIC
BAHA
a
b
Fig. 1 a, b S/N for a speech intelligibility of 50% with everyday
Dutch sentences: with noise presented in front and speech on either
the poor ear (PE) or the best ear (BE). ‘Lateral speech’ in four
conditions: unaided (n = 9), conventional CROS (CROS, n = 8),
completely in the canal (CIC, n = 7) and BAHA CROS (BAHA,
n = 9)
0,0
10,0
20,0
30,0
40,0
50,0
60,0
70,0
80,0
EC BN RV AV
Domains
APHAB
Unaided
CROS
CIC
BAHA
Fig. 2 Mean scores of the 10
patients on the APHAB in the
domains ease of communication
(EC), background noise (BN),
reverberation (RV) and
aversiveness of sound (AV) of
the APHAB in four different
conditions: unaided (n = 10),
conventional CROS (CROS,
n = 8), completely in the canal
(CIC, n = 8) and BAHA CROS
(BAHA, n = 9)
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and very poor with the CIC (3.7).
Following the completion of the trial, the patients were
asked whether they wished to apply for one of the three
CROS devices. Six patients declined, three patients opted
for a BAHA CROS (nos. 6, 8 and 10, see Table 1) and one
patient chose the conventional CROS with FM link (no. 3,
see Table 1). The ﬁrst two BAHA CROS patients have
been implanted and they are satisﬁed with its performance.
The third patient is awaiting surgery. None of the patients
who participated in our trial chose the CIC.
Discussion
In this pilot study, three different unilateral CROS ampli-
ﬁcation options were tested by patients with unilateral
inner ear deafness. The patients’ experience in this pilot
was intended to act as the beginning of a large evidence-
based study for patients with difﬁculties in daily life who
are looking for a solution. The BAHA CROS has been
found to alleviate the head shadow effect [10, 11, 19, 30].
The conventional CROS is known to have its own merits,
but also disadvantages [31]. The completely in the CIC, an
alternative transcranial CROS application, has received
only sparse attention in the literature.
The BAHA CROS is the only system that requires
osseointegration and, therefore, surgery in preparation for
Table 3 Mean scores of the ten patients on the spatial domain of the
SSQ in the four conditions: unaided, conventional CROS (CROS),
completely in the canal (CIC) and BAHA CROS (BAHA)
SSQ Mean Difference
Unaided 3.7 (1.5) .
CROS 5.0 (1.8) ?1.3
CIC 4.0 (1.4) ?0.3
BAHA 4.8 (2.5) ?1.1
0
1
2
3
4
5
6
7
8
9
10
Comfortable Easy Rustle Whistle Failure
Domains
Subjective opinion
CROS
CIC
BAHA
0
1
2
3
4
5
6
7
  No opinion No Yes
Beneficial to  hearing?
CROS
CIC
BAHA
37%
66%
37%
86%
22% 25%
11%
a
b
Fig. 3 a Single-sided deafness
(SSD) questionnaire results,
with the CROS (n = 8), CIC
(n = 7) and the BAHA (n = 9).
Subjective beneﬁt with each
hearing aid was scored in ﬁve
domains (wearing comfort, easy
to use, rustle, whistle and
failure) on a scale from 0 to 10.
b Number of patients who
indicated beneﬁt with one of the
hearing aids is indicated on the
y axis. The percentage is
indicated in the ﬁgure itself
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means of a transcutaneous setup in which the BAHA is
connected to a special plastic disc held in place by a steel
spring headband. If the patients are satisﬁed with this
transcutaneous application, they might experience even
more beneﬁt from the ultimate bone conduction system
after implant surgery.
This pilot study has investigated the experience of ten
patients with three different CROS devices which they
tried out in a random order for equal periods of time. For
logistic reasons, the number was at ﬁrst set on ten patients.
To provide true evidence-based results, a larger study is
required for these treatments in patients with unilateral
sensorineural hearing loss [32, 33].
The directional hearing measurements obtained in this
study conﬁrmed our previous ﬁndings in patients with
unilateral deafness: the results were essentially at chance
level, irrespective of which device the patients were using
[10, 29]. In our setup, the patients were instructed to keep
their head facing to the front. The scores at 3,000 Hz
were somewhat poorer with the CROS and BAHA than in
the unaided condition, but there was a small improvement
with the CIC. However, none of the scores were statis-
tically signiﬁcant. Despite the shortcomings (e.g. low
number of participants with missing data), this was the
ﬁrst random-controlled trial that not only evaluated the
conventional CROS and the BAHA CROS, but also the
CIC. In our opinion, the trend in our results is of value.
The poor sound localization results are in agreement with
the previous studies with larger numbers; binaural hear-
ing cannot be achieved [21]. A remark can be made
concerning the setup of our directional hearing mea-
surements; they do not resemble real life as patients were
instructed to keep their head still and the sounds used are
not everyday sounds. This setup was chosen, however, to
make the pilot group comparable to our previous data.
Further research with more ‘life-like’ tests is still under
construction in our clinic.
A major drawback of this pilot study is the small number
of patients. It was remarkable that the CIC produced
favorable SRT results, but none of the patients ultimately
chose the CIC. This indicates once more that the decision
of a patient to wear a certain hearing aid is not just audi-
ological, but extends beyond the boundaries of objective
results. Our ultimate goal is to achieve an instrument that
will be able to capture these ‘‘non-objective’’ data and turn
them into a valuable tool for preoperative selection.
Patient outcome measures are essential in this evaluation
of patient beneﬁt, still the one and only perfect instrument
does not exist yet. For the moment, we choose those
instruments that were previously used in similar studies for
subjective evaluation. We used three different instruments:
the APHAB, the SSQ and the SSD questionnaire.
In general, the APHAB showed the poorest scores with
the CIC, the best scores with the BAHA and intermediate
scores with the conventional CROS.
To gather subjective information about auditory locali-
zation, the spatial part of the SSQ questionnaire was used.
Some beneﬁt in directional hearing was found with each of
the three devices. The BAHA and the conventional CROS
showed the most beneﬁt (overall improvement of 1.1 and
1.3, respectively). In comparison, Noble and Gatehouse
obtained a mean unaided score of 4.8 from 50 patients with
asymmetrical sensorineural hearing loss [28].
In addition, the general SSD questionnaire was used.
Remarkably, the CIC had the best scores on the SSD items
wearing comfort, easy to use, rustle, whistle and failure.
The average score on several quality of sound items was
best with the conventional CROS (7.0), slightly poorer with
the BAHA (6.8) and very poor with the CIC (3.7).
At the end of this trial, six out of the ten patients did not
choose any of the unilateral ampliﬁcation methods they
tested in this study. The one patient who chose the con-
ventional CROS is using an FM link instead of a wire
around the neck. The two implanted BAHA CROS patients
are satisﬁed with the performance of the device; the third
patient who chose the BAHA CROS is awaiting surgery.
This pilot study was performed to evaluate several items.
Firstofall,ifthedecisionforaspeciﬁcCROShearingaidwas
dependent on the order in which they were trialed? This was
not the case. Second, if we should offer each of our SSD
patients the personally designed CIC? None of the patients
chose the CIC, presumably based on the subjectively experi-
enced poor quality of sound. To answer this question cor-
rectly, we should have veriﬁed to what degree the ampliﬁed
speech was audible to the better hearing ear. However, the
SRT results improve indicating effective ampliﬁcation. We
choose in our clinic to not regularly test the CIC in our SSD
patients, as none of the pilot study patients chose the CIC.
Third, what is the success rate of BAHA CROS in SSD
patients, not necessarily experiencing hearing problems? In
literature, it is reported that 25% of the patients, who under-
went acoustic neuroma surgery, apply for implantation of the
BAHA system after trial on a headband [34]. Our percentage
of 30% (3 out of 10 patients) who chose the BAHA is in
accordance with these reports. Fourth, what are the selection
criteria to preoperatively select a suitable BAHA CROS
patient? This study again shows that the trial of the BAHA
headband is predictive and useful. More research is needed,
however, to develop an instrument to identify the patient that
willbeneﬁtfromaCROShearingaid.Itcanbesuggestedthat,
asHarfordandDodds[1]alreadyfound,thedegreeofsuccess
depends on the motivation of the patient and the listening
demandsimposedbytheirlifestyleandworkingenvironment.
This pilot study showed again that these demands are not
measuredwithinthecurrentlyusedinstruments(APHABand
Eur Arch Otorhinolaryngol (2010) 267:889–896 895
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instrument capturing these demands.
Conclusion
In conclusion, most of the patients experienced some
degree of beneﬁt with each of the three CROS devices, but
it was most of the time not large enough to outweigh the
disadvantages. Preference for one of the three hearing aids
was independent of the order in which they were trialed.
We recommend that all patients with unilateral inner ear
deafness, not only those applying for a hearing aid, but also
those without hearing problems, should be offered a trial
with at least the BAHA CROS on a headband. It would be
worthwhile to formulate selection criteria to help establish
if a CROS hearing aid will be beneﬁcial and preferably also
which CROS hearing aid will suit a speciﬁc patient.
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